Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02917109 · ClinicalTrials.gov registry record · NA
LearningRx Cognitive Training for ADHD
A NA study, sponsored by Gibson Institute of Cognitive Research.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02917109: Completed NA study, sponsored by Gibson Institute of Cognitive Research.
NCT02917109 is a NA study that has completed, run by Gibson Institute of Cognitive Research. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02917109, a NA study, has completed, sponsored by Gibson Institute of Cognitive Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, brain structure, and daily functioning for participants with ADHD.
Primary Outcome
Confirmed by change in pretest to post-test scores on the Woodcock Johnson IV - Tests of Cognitive Abilities
Interventions
- BEHAVIORAL LearningRx cognitive training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT02917109 record still lists
NCT02917109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which LearningRx cognitive training is the first listed.
NCT02917109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02917109 about?
NCT02917109 is a clinical study titled "LearningRx Cognitive Training for ADHD". The purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, brain structure, and daily functioning for participants with ADHD.
What is the current status of trial NCT02917109?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2016-09. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02917109?
The interventions under investigation include: LearningRx cognitive training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02917109?
This trial is sponsored by Gibson Institute of Cognitive Research, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02917109's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia